Analysts expect Xylem Inc. (NYSE:XYL) to post $1.17 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Xylem’s earnings. The lowest sales estimate is $1.12 billion and the highest is $1.19 billion. Xylem posted sales of $897.00 million in the same quarter last year, which suggests a positive year-over-year growth rate of 30.4%. The firm is expected to report its next quarterly earnings results on Tuesday, November 7th.

On average, analysts expect that Xylem will report full-year sales of $1.17 billion for the current financial year, with estimates ranging from $4.58 billion to $4.70 billion. For the next financial year, analysts anticipate that the firm will report sales of $4.92 billion per share, with estimates ranging from $4.86 billion to $5.00 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for Xylem.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, August 1st. The industrial products company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.17 billion. Xylem had a return on equity of 17.26% and a net margin of 6.58%. The business’s revenue was up 24.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 earnings per share.

Several research analysts recently issued reports on XYL shares. CIBC reiterated a “buy” rating on shares of Xylem in a research report on Wednesday, May 10th. Oppenheimer Holdings, Inc. reiterated a “buy” rating on shares of Xylem in a research report on Tuesday, May 9th. Zacks Investment Research upgraded shares of Xylem from a “hold” rating to a “buy” rating and set a $62.00 target price for the company in a research report on Tuesday, July 4th. BidaskClub upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Wednesday, June 28th. Finally, Boenning Scattergood reiterated a “buy” rating and issued a $55.00 target price on shares of Xylem in a research report on Wednesday, June 7th. Five analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Xylem currently has an average rating of “Buy” and an average price target of $59.42.

In other Xylem news, insider Kenneth Napolitano sold 9,052 shares of the company’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $60.16, for a total transaction of $544,568.32. Following the completion of the sale, the insider now directly owns 35,303 shares in the company, valued at $2,123,828.48. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Steven R. Loranger sold 66,132 shares of the company’s stock in a transaction dated Thursday, June 29th. The shares were sold at an average price of $55.01, for a total transaction of $3,637,921.32. Following the sale, the director now owns 65,030 shares of the company’s stock, valued at $3,577,300.30. The disclosure for this sale can be found here. Corporate insiders own 0.75% of the company’s stock.

A number of hedge funds have recently bought and sold shares of XYL. Harfst & Associates Inc. raised its stake in Xylem by 26.1% in the second quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock worth $134,000 after buying an additional 503 shares in the last quarter. CENTRAL TRUST Co raised its stake in Xylem by 160.3% in the second quarter. CENTRAL TRUST Co now owns 2,655 shares of the industrial products company’s stock worth $146,000 after buying an additional 1,635 shares in the last quarter. FNY Partners Fund LP purchased a new stake in Xylem during the first quarter worth $151,000. Tower Research Capital LLC TRC purchased a new stake in Xylem during the second quarter worth $168,000. Finally, Federated Investors Inc. PA raised its stake in Xylem by 5.8% in the second quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after buying an additional 181 shares in the last quarter. Institutional investors and hedge funds own 86.47% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “$1.17 Billion in Sales Expected for Xylem Inc. (XYL) This Quarter” was originally posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/31/1-17-billion-in-sales-expected-for-xylem-inc-xyl-this-quarter.html.

Xylem (NYSE XYL) opened at 61.55 on Thursday. The firm has a 50-day moving average price of $58.12 and a 200-day moving average price of $52.71. Xylem has a 1-year low of $45.60 and a 1-year high of $61.59. The firm has a market cap of $11.05 billion, a price-to-earnings ratio of 39.74 and a beta of 1.18.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 20th. Shareholders of record on Thursday, August 31st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, August 29th. This represents a $0.72 annualized dividend and a yield of 1.17%. Xylem’s payout ratio is 46.45%.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.